Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction

Heart

Volumn 81, Issue 5, 1999, Pages 483-487

  Nagaya, N ^a   Nishikimi, T ^a   Uematsu, M ^a   Yoshitomi, Y ^b   Miyao, Y ^a   Miyazaki, S ^a   Goto, Y ^a   Kojima, S ^b   Kuramochi, M ^b   Matsuo, H ^a   Kangawa, K ^a   Nonogi, H ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Adrenomedullin; Heart failure; Myocardial infarction; Prognosis

Indexed keywords

ADRENOMEDULLIN; AMYLIN; CALCITONIN GENE RELATED PEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; DISULFIDE BOND; DRUG BLOOD LEVEL; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INDEX; HEMODYNAMIC MONITORING; HUMAN; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; VASCULAR SMOOTH MUSCLE;

EID: 0032958260     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.5.483     Document Type: Article

References (22)

1. 1 Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-6.
2. 2 Ichiki Y, Kitamura K, Kangawa K, et al. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994;338:6-10.
3. 3 Ishimitsu T, Nishikimi T, Saito Y, et al. Plasma levels of adrenomedullin, a hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994;94:2158-61.
4. 4 Nakamura M, Yoshida H, Makita S, et al. Potent and long-lasting vasodilatory effects of adrenomedullin in humans: comparisons between normal subjects and patients with chronic heart failure. Circulation 1997;95:1214-21.
5. 5 Miura K, Ebara T, Okumura M, et al. Attenuation of adrenomedullin-induced renal vasodilation by N-nitro-L-arginine but not glibenclamide. Br J Pharmacol 1995;115: 917-24.
6. 6 Majid DSA, Kadowitz PJ, Coy DH, et al. Renal responses to intra-arterial administration of adrenomedullin in dogs. Am J Physiol 1996;270:F200-5.
7. 7 Nishikimi T, Saito Y, Kitamura K, et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995;26:1424-31.
8. 8 Jougasaki M, Wei C-M, McKinley LJ, et al. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995;92:286-9.
9. 9 Miyao Y, Nishikimi T, Miyazaki S, et al. Increased plasma levels of adrenomedullin in patients with acute myocardial infarction in proportion to the clinical severity. Heart 1998; 79:39-44.
10. 10 Kobayashi K, Kitamura K, Hirayama N, et al. Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 1996;131:676-80.
11. 11 Jougasaki M, Rodeheffer RJ, Redfield MM, et al. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 1996;97:2370-6.
12. 12 Nishikimi T, Horio T, Sasaki T, et al. Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension 1997;30:1369-75.
13. 13 Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9.
14. 14 Kitamura K, Ichiki Y, Tanaka M, et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994;341: 288-90.
15. 15 Sandler H, Dodge H. Use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968;75:325-34.
16. 16 Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
17. 17 Sanz G, Castaner A, Betriu A, et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 1982;306:1065-70.
18. 18 Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994;201:1160-6.
19. 19 Sugo S, Minamino N, Shoji H, et al. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995;207:25-32.
20. 20 Nossaman BD, Feng CJ, Kaye AD, et al. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. Am J Physiol 1996;270: L782-9.
21. 21 Hirschl MM, Gwechenberger M, Binder T, et al. Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. Eur Heart J 1996;17:1852-9.
22. 22 Guillen I, Blanes M, Gomez-Lechon M, et al. Cytokine signaling during myocardial infarction: sequential appearance of IL-1β and IL-6. Am J Physiol 1995;269:R229-35.